ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,728.80
0.41%
US Tech 100
19,528.00
0.90%
다우존스 지수
42,052.19
0.69%
Bitcoin
69,303.56
-0.26%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU

  6. Ab Science (AB) 시세

Ab Science

Ab Science (AB)

AllianceBernstein Holding LP
1.016
0.002
(0.20%)
마감 03 11월 1:30AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
1.016
매수가
0.987
매도가
1.018
거래량
12,480
0.99 일간 변동폭 1.016
0.88 52주 범위 4.465
market_cap
52.904M
전일 종가
1.014
개장가
1.01
최근 거래 시간
77
@
1.016
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
32,315
발행 주식
52,071,069
배당수익률
-
주가수익률
-4.43
주당순이익(EPS)
-0.23
매출
970k
순이익
-11.99M

Ab Science 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.ab-science.com
본부
Paris, Paris, Fra
설립됨
-
Ab Science is listed in the Pharmaceutical Preparations sector of the 유로넥스트 (Euronext) with ticker AB. The last closing price for Ab Science was 1.01 €. Over the last year, Ab Science shares have traded in a share price range of 0.88 € to 4.465 €.

Ab Science currently has 52,071,069 shares in issue. The market capitalisation of Ab Science is 52.80 € million. Ab Science has a price to earnings ratio (PE ratio) of -4.43.

AB 최신 뉴스

추가 뉴스

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN...

29 10월 2024
UK Regulatory

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS...

29 10월 2024
UK Regulatory

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE THIS DECISION FURTHER STRENGTHENS MASITINIB’S...

29 10월 2024
GlobeNewswire Inc.

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL...

18 10월 2024
UK Regulatory

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE...

18 10월 2024
UK Regulatory

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 17 October, 2024...

18 10월 2024
GlobeNewswire Inc.

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science          COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS AU PREMIER SEMESTRE...

10 10월 2024
UK Regulatory

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities          PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS...

10 10월 2024
UK Regulatory

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities

         PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS OF THE PERIOD Clinical development Masitinib platform: Ongoing re-examination by...

10 10월 2024
GlobeNewswire Inc.

AB Science annonce avoir réalisé le règlement livraison de sa dernière augmentation de capital de 5,0 millions d’euros

AB Science annonce avoir réalisé le règlement livraison de sa dernière augmentation de capital de 5,0 millions d’euros COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE AVOIR REALISE LE REGLEMENT LIVRAISON...

09 10월 2024
UK Regulatory
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.033.042596348880.9861.050.946460000.99409721DE
40.0181.803607214430.9981.050.88376970.97437854DE
120.066.276150627620.9561.0780.88323150.99548391DE
26-0.88-46.41350210971.8962.2950.88785681.40219382DE
52-1.324-56.58119658122.344.4650.881030712.28505412DE
156-12.034-92.21455938713.0513.340.88952984.80193443DE
260-2.384-70.11764705883.421.750.881472238.4083372DE

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ALAVEAventador
0.0018 €
(28.57%)
93.77M
ALARFAdeunis
0.698 €
(21.18%)
673
BIOSBiosenic
0.0078 €
(18.18%)
3.7M
ALDUBEncres Dubuit
2.60 €
(18.18%)
15.97k
MLNOVNovatech Ind
10.50 €
(17.32%)
32
MLSMLSmalto
0.0115 €
(-25.81%)
658
MLACTActivium Group
1.60 €
(-24.53%)
11
ALVERVergnet
0.0067 €
(-20.24%)
9.37M
FURFugro NV
17.64 €
(-16.24%)
2.96M
ALKALKALRAY SA
0.984 €
(-15.17%)
209.31k
ALAVEAventador
0.0018 €
(28.57%)
93.77M
ALNEVNeovacs
0.0002 €
(0.00%)
65.01M
BCPBanco Comercial Portugues SA
0.4631 €
(-0.06%)
61.48M
ALDOLDolfines
0.0006 €
(0.00%)
48.27M
ALNRGEnergisme SA
0.0066 €
(-8.33%)
15.91M

토론

전체 피드 보기
John_Vallay John_Vallay 2 분 전
Accounts Receivables CAN NOT be booked or moved to revenues.

Accounts Receivables was booked as revenues in the past and now it is under accounts receivables because it is owed to them by someone or some company.

If you look at past quarterly and annual reports you will
BSEG
KVM KVM 2 분 전
GBR got a question. Have been researching Airship. Know you kind of follow them sonce in Ai. Thinking about buying some shares. Any thoughts?
VERI
6of1 6of1 3 분 전
thanks fop the reply. I agree about the RD and publicity. I also think that all the forward thinking tech influencers and implementors are well aware. this is so much bigger than all of the companies you mentioned. I really think we are at the start of a journey that most of us myself included
IONQ
wadegarret wadegarret 3 분 전
HALO- very surprises this board passed Friday

The stock was only in the $53s at the open, and ended up in the $57s. I had bought after hours Thursday for $54.48, as I thought that was a steal. Thing is, the stock was $65 6 weeks ago, and this blowout report was even better than ex
WolfofMia WolfofMia 3 분 전
Oh but I have! I asked for an extra inch too!

Thats why I can tell l, of those who are trying to insert with their BS!
AVXL
Kick Up Kick Up 3 분 전
Interesting week, Lakota! Next week has a lot of unknowns that may impact things. Enjoy your weekend!
CFSU
236T568 236T568 4 분 전
Opinion | New York Times - The Editorial Board

You already know Donald Trump. He is unfit to lead. Watch him. Listen to those who know him best. He tried to subvert an election and remains a threat to democracy. He helped overturn Roe, with terrible consequences. Mr. Trump’s corruptio
SCAMBUSTERKING SCAMBUSTERKING 4 분 전
"...as you are most likely a day trader or "tick flipper" who only cares... Not to mention, every time the company gains traction, there are individuals who buy up a bunch of shares, and then, when the price increases a couple of ticks, they sell all their shares at once, causing everyone to panic
BCAP
blackhawks blackhawks 4 분 전
The two dogs looking away in shame.
Milesblue42 Milesblue42 4 분 전
Toxic Financing is Destroying the Share Price...IMO

The Distrurbing Facts CANNOT Be Disputed currently
RONN
zab zab 4 분 전
https://www.reuters.com/world/us/democratic-lawmakers-request-probe-into-trump-son-in-law-after-reuters-saudi-2024-10-24/

Remember Kushner and his 2 billion from Saudi Arabia, thanks to President Trump, but Republicans again looked the other way.
rooster rooster 4 분 전
This is why democrats should be in front of a firing squad… https://x.com/catturd2/status/1852668773276295636?s=46&t=qLQnO1TjeygtFbhEqQdlmg
Dead On Arrival Dead On Arrival 5 분 전
The guy picking up the trash should not count.
LWLG
spec machine spec machine 5 분 전
The market is finally catching up to the fact that large government (in this case militar) contracts are transformative for a small company like Kraken Robotics

They’ve got a great pathway laid down are they’re executing without compromising

The trading volume is pret
KRKNF
SparklingNavigator24 SparklingNavigator24 5 분 전
Theory, NWBO is a legitimate company that your boss is paying you money to defame. Your libel continues and there are several posts that have a strong potential to put you behind bars. At this point in time intent has been demonstrated and they know who you are, what you are doing, and why. No diffe
NWBO
BDEZ BDEZ 5 분 전
Tell me about it Zard...
learningcurve2020 learningcurve2020 6 분 전
LOL.   That's some positive spin! What happened to the claim here that commercialization and a mega share price would occur at any moment? It just died that's what. For a lousy $5M they just gave away 16M shares in the future on top of interest payments.  And, how much of this goes to pay Advent? Wh
NWBO
pos_stock_hoarder pos_stock_hoarder 6 분 전
When I see this kind of woke insanity I think of the 18 years on those boats landing at Normandy (just to name one example). Then I just get real disgusted. And good for Jerry calling this the nonsense that it is.
Kick Up Kick Up 6 분 전
Lakota, it appears things are stabilizing across the board on a few stocks. The large gap on INOI is closing a bit. It’s got my interest at the moment!
IONI
Wolf-man jack Wolf-man jack 7 분 전
WQLF SAYS: CV Sciences Wholly Owned Subsidiary

https://veggs.eu/

https://culturedfoods.eu/our-products

CULTURED FOODS SP. Z O.O.

HEAD OFFICE:
ul. Moscickiego 1
24-110 Pulawy, Poland
PLANT:
ul. Raszynska 22 B
CVSI
glenn1919 glenn1919 7 분 전
ACRS.......PLBY........ENSC.......GRI......FCEL..............https://stockcharts.com/h-sc/ui?s=GRI&p=W&b=5&g=0&id=p84354014936
ACRS ENSC FCEL
KPIFF-LDDFF KPIFF-LDDFF 7 분 전
Belgium, Netherlands, & BAE...
🧐🧐🧐

https://www.linkedin.com/posts/baesystemsinc_euronaval-activity-7258448042104
KPIFF
Konaploinks Konaploinks 8 분 전
Supercharge your business. Step up to , life in The Quantum Lane.
IONQ
Jack_Herer Jack_Herer 8 분 전
Terrific! Looking forward to seeing a real MRE technical report (either NI 43-101 or JORC is fine) on the mineral resource estimation detailing all of the recent drilling conducted since the small exploration drilling program from the 1960's plus ERM's detailed mining plan and financial analysis (a
HIRU
PutzMueler PutzMueler 8 분 전
Thanks, humorous and pointed.

But there’s so much more, don’t you think?


Who sold and who bought Friday?
I wish it was me! But I didn’t know!

Shrug
NB

최근 히스토리

EU
AB
Ab Science
NYSE
TWN
Taiwan
BIT
UB3562
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유